Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13730-020-00512-7 http://scihub22266oqcxt.onion/10.1007/s13730-020-00512-7 32715376!7382919!32715376     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       CEN+Case+Rep 2021 ; 10 (1): 42-45 Nephropedia Template TP {{tp|p=32715376|t=2021. Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia |pdf=|usr=}}{{32715376}} gab.com Text Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia JO: CEN Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32715376 #FOAvip Novel coronavirus disease 2019 (COVID-19) is a highly infectious and deadly disease, spreading worldwide. There are limited data about the clinical course of end-stage renal disease (ESRD) patients infected with COVID-19. However, previous cohort studies showed a high mortality rate of ESRD patients infected with COVID-19. We report here two Japanese ESRD patients confirmed with severe COVID-19 pneumonia. Case 1 was a 60-year-old man with ESRD due to diabetic nephropathy who were infected with COVID-19 and exhibited acute respiratory distress syndrome (ARDS) requiring mechanical ventilation and intensive care unit (ICU) admission. He was treated with tocilizumab and intravenous immunoglobulin (IVIG). After 6 days of treatment in ICU, he was extubated. Case 2 was a 68-year-old woman undergoing maintenance hemodialysis for 17 years who also exhibited ARDS due to COVID-19. Her clinical course resembles case 1. Our experience of these two cases indicates that anti-cytokine therapy might be effective for severe COVID-19 pneumonia in ESRD patients. Twit Text FOAVip Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia ????CEN Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=32715376 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32715376 #FOAvip English Wikipedia <ref>{{Cite pmid|32715376}}</ref> Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia #MMPMID32715376 Abe T; Izumo T; Ueda A; Hayashi M; Ishibashi Y CEN Case Rep 2021[Feb]; 10 (1): 42-45 PMID32715376show ga Novel coronavirus disease 2019 (COVID-19) is a highly infectious and deadly disease, spreading worldwide. There are limited data about the clinical course of end-stage renal disease (ESRD) patients infected with COVID-19. However, previous cohort studies showed a high mortality rate of ESRD patients infected with COVID-19. We report here two Japanese ESRD patients confirmed with severe COVID-19 pneumonia. Case 1 was a 60-year-old man with ESRD due to diabetic nephropathy who were infected with COVID-19 and exhibited acute respiratory distress syndrome (ARDS) requiring mechanical ventilation and intensive care unit (ICU) admission. He was treated with tocilizumab and intravenous immunoglobulin (IVIG). After 6 days of treatment in ICU, he was extubated. Case 2 was a 68-year-old woman undergoing maintenance hemodialysis for 17 years who also exhibited ARDS due to COVID-19. Her clinical course resembles case 1. Our experience of these two cases indicates that anti-cytokine therapy might be effective for severe COVID-19 pneumonia in ESRD patients. |Aged[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antiviral Agents/therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/*complications/*therapy[MESH] |Critical Care[MESH] |Female[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Japan[MESH] |Kidney Failure, Chronic/*complications/therapy[MESH] |Male[MESH] |Renal Dialysis[MESH] |Respiration, Artificial[MESH]Successful treatment of two Japanese ESRD cases with severe COVID-19 p(epmc).pdf DeepDyve Pubget Overpricing